AACR21: iTeos busts out early human data for anti-TIGIT antibody. Is it enough to match up with Roche, Merck?
The TIGIT protein has turned into an arms race for Big Pharma, with Merck and Roche looking to add their own candidates to checkpoint inhibitor …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
